| Issue |
Article |
Total Access |
Authors |
Journal Dept. |
| Vol. 30, No. 3, March 2010 | Drug Interaction Between Clopidogrel and Proton Pump Inhibitors | 3613 | Tina J. Liu, Pharm.D., and Cynthia A. Jackevicius, Pharm.D., M.Sc. | Review of Therapeutics |
| Vol. 29, No. 5, May 2009 | Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis | 2548 | Brett H. Heintz, Pharm.D., Gary R. Matzke, Pharm.D., FCCP, FCP, FASN, and William E. Dager, Pharm.D., FCSHP, FCCP, FCCM | Review of Therapeutics |
| Vol. 30, No. 1, January 2010 | Drug Fever | 1937 | Ruchi A. Patel, Pharm.D., and Jason C. Gallagher, Pharm.D. | Review of Therapeutics |
| Vol. 29, No. 6, June 2009 | Attention-Deficit–Hyperactivity Disorder: An Update | 2545 | Julie A. Dopheide, Pharm.D., and Steven R. Pliszka, M.D. | Review of Therapeutics |
| Vol. 27, No. 8, August 2007 | Antimicrobial Dosing Considerations in Obese Adult Patients: Insights from the Society of Infectious Diseases Pharmacists | 2513 | Manjunath P. Pai, Pharm.D., and David T. Bearden, Pharm.D. | Special Article (SIDP) |
| Vol. 30, No. 6, June 2010 | Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria: Insights from the Society of Infectious Diseases Pharmacists | 1970 | Jennifer Le, Pharm.D., Elizabeth Dodds Ashley, Pharm.D., MHS, Melinda M. Neuhauser, Pharm.D., MPH, et al; and Society of Infectious Diseases Pharmacists Aerosolized Antimicrobials Task Force | Review of Therapeutics (SIDP) |
| Vol. 30, No. 4, April 2010 | Ceftaroline: A New Cephalosporin with Activity Against Resistant Gram-positive Pathogens | 2009 | Molly E. Steed, Pharm.D., and Michael J. Rybak, Pharm.D., MPH | Review of Therapeutics |
| Vol. 30, No. 2, February 2010 | Role of Lactobacillus in the Prevention of Antibiotic-Associated Diarrhea: A Meta-analysis | 1909 | Pramodini B. Kale-Pradhan, Pharm.D., Harjot K. Jassal, and Sheila M. Wilhelm, Pharm.D. | Original Research Article |
| Vol. 29, No. 10, October 2009 | Treatment of Hepatorenal Syndrome | 2125 | Tyree H. Kiser, Pharm.D., Robert MacLaren, Pharm.D., and Douglas N. Fish, Pharm.D. | Review of Therapeutics |
| Vol. 30, No. 8, August 2010 | Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study | 1777 | Rolf P. Kreutz, M.D., Eric J. Stanek, Pharm.D., Ronald Aubert, Ph.D., et al | Original Research Article |